Encephalopathy in acute leukaemia associated with methotrexate therapy.
D000208:Acute Disease; D000328:Adult; D001259:Ataxia / Q000139:chemically induced; D001927:Brain Diseases / Q000139:chemically induced*; D002648:Child; D002675:Child, Preschool; D003072:Cognition Disorders / Q000139:chemically induced; D004569:Electroencephalography; D004827:Epilepsy / Q000139:chemically induced; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007278:Injections, Spinal; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male; D008578:Meninges; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000209:etiology; D014202:Tremor / Q000139:chemically induced
D005492:Folic Acid; D008727:Methotrexate